Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study
Résumé
INTRODUCTION: The presence of cytomegalovirus (CMV) immunoglobulin M (IgM) in human immunodeficiency virus (HIV)-positive individuals indicates an active infection or reactivation of the virus. METHODOLOGY: This study investigated the seroprevalence of CMV IgM antibodies among HIV-positive individuals attending the Ahmadu Bello University Teaching Hospital in Nigeria. RESULTS: Fifty nine out of 92 participants who were tested with an enzyme-linked immunosorbent assay (ELISA) were positive for CMV IgM, resulting in a prevalence rate of 64.1%. Analysis of sociodemographic variables revealed a statistically significant association between CMV IgM seropositivity, and both gender and residence of the participants. Clinical variables also indicated a significant association between CMV IgM seropositivity and the duration of HIV infection. Multivariate analysis showed that participants in the 18-29 years age group, those with a secondary education level, the unemployed, and those who had been infected with HIV for 1-3 years were most likely to test positive for CMV infection. Joint and muscle pain were the most commonly reported symptoms among participants. CONCLUSIONS: The high seroprevalence of CMV IgM antibodies found in this study suggests that CMV infection is widespread in the study area. Therefore, it is essential to regularly screen HIV-positive individuals for CMV during routine antiretroviral therapy visits to enable early detection and improve treatment outcomes.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →